Brief: BCAL Diagnostics Establishes A$10 Million Convertible Note Facility
20/10/2025 02:20
Oct 20 (Reuters) - BCAL Diagnostics Ltd BDX.AX: ESTABLISHES A$10 MILLION CONVERTIBLE NOTE FACILITY Further company coverage: BDX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BCAL Diagnostics
See all newsAustralia's Genetic Signatures urges largest stakeholder to clarify merger intentions; shares rise
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures